You are here
Resources - In the News
WHO HIV & AIDS guidelines for PMTCT & Breastfeeding
In July 2010, the World Health Organization (WHO) issued new HIV and AIDS guidelines on PMTCT (preventing mother to child transmission) and on HIV and breastfeeding. For both PMTCT and for infant feeding there are major differences between these 2010 recommendations and the previous guidance issued in 2006.
Download the Complete WHO Guidelines
Download the Fact Sheet
The WHO states the following key recommendations of the new guidance on ARV drugs for treatment of pregnant women and prevention of HIV in infants are as follows:
- Earlier antiretroviral therapy (ART) for a larger group of HIV-positive pregnant women to benefit both the health of the mother and prevent HIV transmission to her child during pregnancy and breastfeeding.
- Longer provision of antiretroviral (ARV) prophylaxis for HIV-positive pregnant women with relatively strong immune systems who do not need ART for their own health. This would reduce the risk of HIV transmission from mother to child.
- Provision of ARV prophylaxis to the mother or child to reduce the risk of HIV transmission during the breastfeeding period. For the first time, there is enough evidence for WHO to recommend ARVs while breastfeeding.
For additional information on these guidelines as well as other WHO publications, please visit the WHO website.